Unknown NA INTERVENTIONAL NCT00276718

Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors

Germ Cell Tumour Study II

Sponsor: Children's Cancer and Leukaemia Group

Conditions Brain and Central Nervous System Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Ovarian Cancer

Interventions bleomycin sulfate carboplatin conventional surgery etoposide

Updated 6 times since 2017 Last updated: Sep 16, 2013 Started: Apr 30, 1989

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Brain and Central Nervous System Tumors and Childhood Germ Cell Tumor, this trial is ongoing. The trial is conducted by Children's Cancer and Leukaemia Group and has accumulated 6 data snapshots since 1989. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Apr 1989

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Children's Cancer and Leukaemia Group

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aberdeen, United Kingdom , Belfast, United Kingdom , Birmingham, United Kingdom , Bristol, United Kingdom , Cambridge, United Kingdom , Cardiff, United Kingdom , Dublin, Ireland , Edinburgh, United Kingdom , Glasgow, United Kingdom , Leeds, United Kingdom and 10 more locations